The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy

References

• McGuire S. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015. Adv Nutr. 2016;7(2):418–419. doi:10.3945/an.116.012211
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–507. doi:10.1186/s40880-015-0042-6
   PubMedGoogle Scholar
• Li C, Yin M, Wang LE, et al. Polymorphisms of nucleotide excision repair genes predict melanoma survival. J Invest Dermatol. 2013;133(7):1813–1821. doi:10.1038/jid.2012.498
   Web of Science ®Google Scholar
• Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367–1380. doi:10.1056/NEJMra0802714
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311. doi:10.1016/S0140-6736(16)30958-8
   PubMed Web of Science ®Google Scholar
• Way K. Working against racism. Interview by Lyndon Keene. N Z Nurs J. 1988;81(8):17–19.
   Google Scholar
• Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355(24):2542–2550. doi:10.1056/NEJMoa061884
   PubMed Web of Science ®Google Scholar
• Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26(21):3543–3551. doi:10.1200/JCO.2007.15.0375
   PubMed Web of Science ®Google Scholar
• Berschneider B, Konigshoff M. WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease. Int J Biochem Cell Biol. 2011;43(3):306–309. doi:10.1016/j.biocel.2010.11.013
   PubMed Web of Science ®Google Scholar
• Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A. 1998;95(25):14717–14722. doi:10.1073/pnas.95.25.14717
   PubMed Web of Science ®Google Scholar
• Jun JI, Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov. 2011;10(12):945–963. doi:10.1038/nrd3599
   PubMed Web of Science ®Google Scholar
• Venkatesan B, Prabhu SD, Venkatachalam K, et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal. 2010;22(5):809–820. doi:10.1016/j.cellsig.2010.01.005
   PubMed Web of Science ®Google Scholar
• Venkatachalam K, Venkatesan B, Valente AJ, et al. WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem. 2009;284(21):14414–14427. doi:10.1074/jbc.M809757200
   PubMed Web of Science ®Google Scholar
• Inkson CA, Ono M, Bi Y, Kuznetsov SA, Fisher LW, Young MF. The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs. 2009;189(1–4):153–157. doi:10.1159/000151377
   Web of Science ®Google Scholar
• Colston JT, de la Rosa SD, Koehler M, et al. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. Am J Physiol Heart Circ Physiol. 2007;293(3):H1839–1846. doi:10.1152/ajpheart.00428.2007
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thorgeirsson SS. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol. 2005;42(6):842–849. doi:10.1016/j.jhep.2005.01.029
   Web of Science ®Google Scholar
• Margalit O, Eisenbach L, Amariglio N, et al. Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines. Br J Cancer. 2003;89(2):314–319. doi:10.1038/sj.bjc.6600977
   Web of Science ®Google Scholar
• Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 2001;61(24):8917–8923.
   Web of Science ®Google Scholar
• Seal A, Gupta A, Mahalaxmi M, Aykkal R, Singh TR, Arunachalam V. Tools, resources and databases for SNPs and indels in sequences: a review. Int J Bioinform Res Appl. 2014;10(3):264–296. doi:10.1504/IJBRA.2014.060762
   PubMedGoogle Scholar
• Shastry BS. SNP alleles in human disease and evolution. J Hum Genet. 2002;47(11):561–566. doi:10.1007/s100380200086
   PubMed Web of Science ®Google Scholar
• Inkson CA, Ono M, Kuznetsov SA, Fisher LW, Robey PG, Young MF. TGF-beta1 and WISP-1/CCN-4 can regulate each other’s activity to cooperatively control osteoblast function. J Cell Biochem. 2008;104(5):1865–1878. doi:10.1002/jcb.21754
   Web of Science ®Google Scholar
• Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12(7):676–685. doi:10.1038/ncb2070
   PubMed Web of Science ®Google Scholar
• Tian C, Zhou ZG, Meng WJ, et al. Overexpression of connective tissue growth factor WISP-1 in Chinese primary rectal cancer patients. World J Gastroenterol. 2007;13(28):3878–3882. doi:10.3748/wjg.v13.i28.3878
   Web of Science ®Google Scholar
• Nagai Y, Watanabe M, Ishikawa S, et al. Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma. Anticancer Res. 2011;31(3):991–997.
   PubMed Web of Science ®Google Scholar
• Wu J, Long Z, Cai H, et al. High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis. Oncotarget. 2016;7(31):49834–49847. doi:10.18632/oncotarget.10486
   PubMedGoogle Scholar
• Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene. 2011;30(42):4316–4326. doi:10.1038/onc.2011.142
   Web of Science ®Google Scholar
• Chen J, Yin J, Li X, et al. WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients. Int J Mol Sci. 2014;15(11):21011–21027. doi:10.3390/ijms151121011
   Web of Science ®Google Scholar
• Chen J, Yin JY, Li XP, et al. Association of Wnt-inducible signaling pathway protein 1 genetic polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Clin Lung Cancer. 2015;16(4):298. doi:10.1016/j.cllc.2014.12.008
   PubMed Web of Science ®Google Scholar
• Gaudreau PO, Clairefond S, Class CA, et al. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors. Oncoimmunology. 2019;8(5):e1581545. doi:10.1080/2162402X.2019.1581545
   PubMed Web of Science ®Google Scholar
• Blom AB, Brockbank SM, van Lent PL, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 2009;60(2):501–512. doi:10.1002/art.24247
   PubMed Web of Science ®Google Scholar
• Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 2000;14(5):585–595.
   PubMed Web of Science ®Google Scholar
• Su F, Overholtzer M, Besser D, Levine AJ. WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. Genes Dev. 2002;16(1):46–57. doi:10.1101/gad.942902
   Web of Science ®Google Scholar
• You Z, Saims D, Chen S, et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol. 2002;157(3):429–440. doi:10.1083/jcb.200201110
   PubMed Web of Science ®Google Scholar
• Konigshoff M, Kramer M, Balsara N, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest. 2009;119(4):772–787.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang R, Wen S, McCafferty DM, Beck PL, MacNaughton WK. Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis. J Mol Med. 2009;87(4):435–445. doi:10.1007/s00109-009-0445-4
   Web of Science ®Google Scholar
• Witte F, Dokas J, Neuendorf F, Mundlos S, Stricker S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr Patterns. 2009;9(4):215–223. doi:10.1016/j.gep.2008.12.009
   Web of Science ®Google Scholar
• Sharma S, Tantisira K, Carey V, et al. A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am J Respir Crit Care Med. 2010;181(4):328–336. doi:10.1164/rccm.200907-1009OC
   PubMed Web of Science ®Google Scholar
• Lee HL, Chiou HL, Wang SS, et al. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma. Urol Oncol. 2018;36(4):160e115–160e121. doi:10.1016/j.urolonc.2017.11.023
   Web of Science ®Google Scholar
• Liu Y, Qin W, Zhang F, et al. Association between WNT-1-inducible signaling pathway protein-1 (WISP1) genetic polymorphisms and the risk of gastric cancer in Guangxi Chinese. Cancer Cell Int. 2021;21(1):405. doi:10.1186/s12935-021-02116-2
   Web of Science ®Google Scholar